Back to search results

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

Abroad (travel likely)RecruitingPHASE2

Conditions

Advanced Cholangiocarcinoma · FGFR2 Fusions · Gene Rearrangement

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California San Diego UCSD - Moores Cancer Center, La Jolla, California, United States

    Study coordinator · aburgoyne@health.ucsd.edu · 858-657-7000
    Contact: Principal Investigator (Burgoyne Adam)

  • Tampa General Hospital Cancer Institute, Tampa, Florida, United States

  • Henry Ford Health System, Detroit, Michigan, United States

    Study coordinator · pphilip1@hfhs.org · 888-734-5322
    Contact: Principal Investigator (Philip Philip)

  • Gabrail Cancer Center Research, Canton, Ohio, United States

  • Texas Oncology, Abilene, Texas, United States

    Study coordinator · anton.melnyk@usoncology.com · 325-692-0188
    Contact: Principal Investigator (Melynk Anton)

  • The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States

    Study coordinator · ParvezMantry@mhd.com · 214-947-4450
    Contact: Principal Investigator (Parvez Mantry)

  • Texas Oncology Methodist DFW, Dallas, Texas, United States

  • Texas Onc Methodist (Charlton), Dallas, Texas, United States

  • Texas Oncology - Northeast, Denton, Texas, United States

  • Center for Oncology and Blood Disorders, Houston, Texas, United States

  • Hospital Britanico, Buenos Aires, Argentina

    Study coordinator · lubq1@yahoo.com.ar · +54 4309-6400
    Contact: Principal Investigator (Luciana Bella Quero)

  • CEMIC, CABA, Argentina

    Study coordinator · julieta.grasselli@gmail.com · +54 5299-0100
    Contact: Principal Investigator (Julieta Grasselli)

  • Sanatorio de la Mujer, Rosario, Argentina

    Study coordinator · cristina_nasurdi@hotmail.com · +54 640-5260
    Contact: Principal Investigator (Cristina Nasurdi)

  • St Vincent's Hospital Sydney - The Kinghorn Cancer Centre, Sydney, New South Wales, Australia

    Contact: Principal Investigator (Hao-Wen Sim)

  • Alfred Health, Medical Oncology Unit, Second floor William Buckland Radiotherapy Center, Melbourne, Victoria, Australia

    Contact: Principal Investigator (Sanjeev Gill)

  • St John of God Subiaco Hospital, Subiaco, Western Australia, Australia

  • Instituto do Cancer do Estado de Sao Paulo, Cerqueira César, Brazil

    Study coordinator · marlene.salgado@hc.fm.usp.br · +55 11 9 9644-6112
    Contact: Principal Investigator (Camila Motta Venchiarutti Moniz)

  • IOP - Instituto de Oncologia do Parana, Curitiba, Brazil

    Study coordinator · mariana.brandao@iop.com.br · +55 3207-9788
    Contact: Principal Investigator (Luciano Semensato Biela)

  • Hospital Erasto Gaertner, Curitiba, Brazil

    Study coordinator · andressaschuta@gmail.com · +55 3361-5195
    Contact: Principal Investigator (Andressa Ribas)

  • Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto, Brazil

    Study coordinator · caldeira.kamylla@gmail.com · + 55 3201-5054
    Contact: Principal Investigator (Kathia Cristina Abadalla)

  • Fundacao Antonio Prudente - A.C.Camargo Cancer Center, São Paulo, Brazil

    Study coordinator · tiago.felismino@accamargo.org.br · +55 11 98565-9911
    Contact: Principal Investigator (Tiago Felismino)

  • Grand River Hospital - Grand River Regional Cancer Centre (GRRCC), Kitchener, OH, Canada

  • Sunnybrook Health Sciences Center, Toronto, OH, Canada

  • University of Toronto, Toronto, OH, Canada

  • McGill University Health Center, Montreal, Quebec, Canada

  • Guangdong Provincial People's Hospitall, Guangzhou, Guangdong, China

    Study coordinator · madong8005@126.com · 020-81884713
    Contact: Principal Investigator (Dong Ma)

  • Harbin Medical University - Cancer Hospital, Harbin, Heilongjiang, China

    Study coordinator · byxlcyj@126.com · 13945095085
    Contact: Principal Investigator (Yuxian Bai)

  • Jiangsu Provance Hospital, Nanjing, Jiangsu, China

  • Jilin Cancer Hospital, Changchun, Jilin, China

    Study coordinator · chengying@csco.org.cn · 0431-80596315
    Contact: Principal Investigator (Ying Cheng)

  • Shandong University - Shandong Cancer Hospital, Jinan, Shandong, China

    Study coordinator · dangqi123456@126.com · 15318816098
    Contact: Principal Investigator (Qi Dang)

  • Zhongahan Hospital Fudan unversity, Shanghai, Shanghai Municipality, China

  • West China Hospital- Sichuan University, Chengdu, Sichuan, China

    Study coordinator · caodan@wchscu.cn · 18980605963
    Contact: Principal Investigator (Dan Cao)

  • Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, China

    Study coordinator · shonco@sina.com · 13605716662
    Contact: Principal Investigator (Hongming Pan)

  • Shanghai Gobroad Cancer Hospital China Pharmaceutical University, Shanghai, China

    Study coordinator · lijin@csco.org.cn · 13661222111
    Contact: Principal Investigator (Jin Li)

  • Tongji University Shanghai East Hospital, Shanghai, China

  • The University of Hong Kong, Hong Kong Island, Hong Kong

  • The Chinese University of Hong Kong Prince of Wales Hospital, New Territories, Hong Kong

  • Policlinico S. Orsola-Malpighi, Bologna, Italy

    Study coordinator · giovanni.brandi@unibo.it · 0039 051 636 3838
    Contact: Principal Investigator (Giovanni Brandi)

  • IRCCS Humanitas Research Hospital, Rozzano, Italy

    Study coordinator · lorenza.rimassa@hunimed.eu · 0039 0282244573
    Contact: Principal Investigator (Lorenza Rimassa)

  • AOUI Verona - Ospedale Borgo Roma, Verona, Italy

    Study coordinator · davide.melisi@gmail.com · 0039 045 812 8174
    Contact: Principal Investigator (Davide Melisi)

  • Tohoku University Hospital, Sendai, Miyagi, Japan

    Study coordinator · maeda.shimpei@surg.med.tohoku.ac.jp · 0081 22 717 7000

  • National Cancer Center Hospital East, Kashiwa-Shi, Japan

    Study coordinator · kazuowat@east.ncc.go.jp · 81958197200
    Contact: Principal Investigator (Susumu Watanabe)

  • Nagasaki University Hospital, Nagasaki, Japan

    Contact: Study coordinator (Susumu Eguchi) · Sueguchi@nagasaki-uc.ac.jp · 0081 4 7133 1111
    Contact: Principal Investigator (Susumu Eguchi)

  • Nagoya University Hospital, Nagoya, Japan

    Study coordinator · tmzn@med.nagoya-u.ac.jp · 0081 52 741-2111
    Contact: Principal Investigator (Takashi Mizuno)

  • Osaka Metropolitan University Hospital, Osaka-Fu, Japan

    Study coordinator · m1297198@msic.med.osaka-cu.ac.jp · 0081 6 6645 2121
    Contact: Principal Investigator (Hiroji Shinkawa)

  • Szpital Wojewdzki w Koszalinie im. Mikoaja Kopernika, Koszalin, Poland

  • Centrum Onkologii Ziemi Lubelskiej im. w. Jana z Dukli, Lublin, Poland

  • Europejskie Centrum Zdrowia Otwock Sp. Z.o.o., Otwock, Poland

    Study coordinator · cezary.szczylik@ecz-otwock.pl · +48 227 103 035
    Contact: Principal Investigator (Cezary Szcylik)

  • Centrum Onkologii-Instytut im. Marii Skłodowskiej - Curie, Warsaw, Poland

    Study coordinator · lucjan.wrywicz@nio.gov.pl · 0048 506159219
    Contact: Principal Investigator (Lucjan Wyrwicz)

  • Fundação Champalimaud, Lisbon, Portugal

    Study coordinator · nuno.couto@fundacaochampalimaud.pt · 00351 210 480 048
    Contact: Principal Investigator (Nuno Couto)

  • Centro Hospitalar Lisboa Norte CHLN EPE - Hospital de Santa Maria, Lisbon, Portugal

    Study coordinator · g.nogueiradacosta@gamil.com · 00351 966 512 445
    Contact: Principal Investigator (Catarina Abreu)

  • Inje University Haeundae Paik Hospital, Busan, South Korea

    Study coordinator · onelement@daum.net · +82 51 797 0009
    Contact: Principal Investigator (Il Hwan Kim)

  • Dong-A University Hospital, Busan, South Korea

  • Kyungpook National University Hospital, Daegu, South Korea

    Study coordinator · wytak@knu.ac.kr · 82 200-5519
    Contact: Principal Investigator (Won Young Tak)

  • Gyeongsang National University Hospital, Jinju, South Korea

    Study coordinator · newatp@naver.com · +82 55 750 8053
    Contact: Principal Investigator (Jung Hun Kang)

  • CHA Bundang Medical Center, Seongnam, South Korea

    Study coordinator · hongjaechon@gmail.com · +82 31 780 5000
    Contact: Principal Investigator (Hongjae Chon)

  • Yonsei University Health System - Severance Hospital, Seoul, South Korea

    Study coordinator · choihj@yuhs.ac · +82 2 2228 8133
    Contact: Principal Investigator (Hye Jin Choi)

  • The Catholic University of Korea, St. Mary's Hospital, Seoul, South Korea

    Study coordinator · angelamd@catholic.ac.kr · 82 22586044
    Contact: Principal Investigator (Myung Ah Lee)

  • Hospital Vall d'Hebron, Barcelona, Spain

    Study coordinator · tmacarulla@gmail.com · 34-914-269394
    Contact: Principal Investigator (Teresa Macarulla Mercadé)

  • Institut Català d'Oncologia de l'Hospitalet de Llobregat - Hospital Duran i Reynals, Barcelona, Spain

    Study coordinator · blaquente@iconcologia.net · 34-260
    Contact: Principal Investigator (Berta Laquente Saez)

  • Hospital General Universitario Gregorio Maranon, Madrid, Spain

    Study coordinator · 0034 91 586 81 61
    Contact: Principal Investigator (Andres J. Munoz Martin)

  • Clinica Universidad de Navarra, Medical Oncology Service (Mariano Ponz Sarvise), Madrid, Spain

    Study coordinator · mponz@unav.es · 0034913531920
    Contact: Principal Investigator (Mariano Ponz-Sarvise)

  • Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain

    Study coordinator · angela.lamarca@quironsalud.es · +34 648444925
    Contact: Principal Investigator (Angela Lamarca)

  • Hospital Universitario 12 de octubre, Madrid, Spain

    Study coordinator · drcofi@hotmail.com · 34-908-926
    Contact: Principal Investigator (Jorge Adeva Alfonso)

  • Clinica Universidad de Navarra, Pamplona, Spain

    Study coordinator · eecc@unav.es · 34-255 400
    Contact: Principal Investigator (Mariano Ponz-Sarvise)
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)